Canada markets close in 1 hour 59 minutes

Hansa Biopharma AB (publ) (0RC7.IL)

IOB - IOB Delayed Price. Currency in SEK
Add to watchlist
38.76+0.06 (+0.16%)
At close: 05:33PM BST
Currency in SEK

Valuation Measures4

Market Cap (intraday) 2.44B
Enterprise Value 2.85B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)12.27
Price/Book (mrq)7.33
Enterprise Value/Revenue 17.16
Enterprise Value/EBITDA -3.35

Trading Information

Stock Price History

Beta (5Y Monthly) 1.05
52-Week Change 3-30.68%
S&P500 52-Week Change 328.04%
52 Week High 356.00
52 Week Low 320.74
50-Day Moving Average 330.38
200-Day Moving Average 331.62

Share Statistics

Avg Vol (3 month) 33.9k
Avg Vol (10 day) 32.6k
Shares Outstanding 552.67M
Implied Shares Outstanding 61.42M
Float 838.42M
% Held by Insiders 110.00%
% Held by Institutions 136.38%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-431.06%

Management Effectiveness

Return on Assets (ttm)-39.82%
Return on Equity (ttm)-228.62%

Income Statement

Revenue (ttm)158.7M
Revenue Per Share (ttm)3.24
Quarterly Revenue Growth (yoy)38.90%
Gross Profit (ttm)116.05M
EBITDA -681.21M
Net Income Avi to Common (ttm)-759.23M
Diluted EPS (ttm)-16.03
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.1B
Total Cash Per Share (mrq)21.02
Total Debt (mrq)865.85M
Total Debt/Equity (mrq)475.26%
Current Ratio (mrq)4.09
Book Value Per Share (mrq)3.47

Cash Flow Statement

Operating Cash Flow (ttm)-625.54M
Levered Free Cash Flow (ttm)-368.35M